GlaxoSmithKline recruits a new coach and top player for their AI/ML team out of Genentech and MIT
GSK R&D chief Hal Barron is aiming high for the pharma giant’s crew for artificial intelligence and machine learning. I learned this week that GSK poached their new chief of the AI/ML group from Genentech, tapping that talent-rich tech zone in South San Francisco which Barron — long based in the Bay Area — always intended to recruit from.
Genentech, with its storied past and high-profile presence in the drug development field, is also where Barron made his mark. And recruiting Kim Branson — who was head of AI, early clinical development at Genentech — adds to his list of local recruits, which includes Kevin Sin, now running BD for GSK out of the Bay Area.
Basic subscription required
Unlock this story instantly and join 55,200+ biopharma pros reading Endpoints daily — and it's free.